State Street’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$213K Sell
464,700
-48,000
-9% -$44.3K ﹤0.01% 3869
2025
Q4
$1.13M Buy
512,700
+471,900
+1,157% +$760K ﹤0.01% 3503
2025
Q3
$64.9K Hold
40,800
﹤0.01% 4123
2025
Q2
$66.1K Sell
40,800
-122,198
-75% -$197K ﹤0.01% 4048
2025
Q1
$194K Sell
162,998
-2,400
-1% -$3.83K ﹤0.01% 3833
2024
Q4
$341K Buy
165,398
+51,983
+46% +$121K ﹤0.01% 3725
2024
Q3
$287K Buy
113,415
+63,968
+129% +$209K ﹤0.01% 3734
2024
Q2
$211K Buy
49,447
+19,847
+67% +$128K ﹤0.01% 3810
2024
Q1
$219K Buy
+29,600
New +$249K ﹤0.01% 3857

Other funds holding GUTS

State Street's GUTS Position: Q1 2026 in Review

State Street reduced its Fractyl Health (GUTS) stake by 9.4% in Q1 2026, selling an estimated $44.3K and leaving 464,700 shares worth $213K. The position accounts for ﹤0.01% of the portfolio, ranked #3869.

State Street first reported a position in GUTS in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.13M in Q4 2025. 83 funds tracked by Wall St. Rank hold GUTS as of Q1 2026.

  • State Street held 464,700 shares of Fractyl Health worth $213K as of Q1 2026.
  • State Street sold 48,000 Fractyl Health shares in Q1 2026, an estimated $44.3K.
  • Fractyl Health made up ﹤0.01% of State Street's portfolio in Q1 2026, its #3869 holding.
  • State Street first reported a position in Fractyl Health in Q1 2024 and has held it in 9 quarters since.
  • State Street's Fractyl Health position peaked at $1.13M in Q4 2025.
  • 83 funds tracked by Wall St. Rank held Fractyl Health as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.